Board of Trustees has named Kristen Clifford the organization's next President and Chief Executive Officer, effective January 13, 2025. "We believe Kristen's vast experience in healthcare ...
MitoRx Therapeutics (MitoRx), a platform biotechnology company developing novel mitochondrial-targeted sulfide-donor therapeutics (mtH2SD) in obesity-related disorders and myopathies announces the ...
The acclaimed television series, Behind the Mysterytm, will bring its unique blend of storytelling and impact to Chicago's own Shriners Children's Hospital on January 14, 2025. Known for raising ...
Recent breakthroughs in DNA research have unveiled promising developments in anti-aging therapies centered around Nicotinamide Mononucleotide (NMN), a naturally occurring molecule crucial for cellular ...